Persistent infection with human papillomavirus (HPV) initiates~ 5% of all human cancers,
and particularly cervical and oropharyngeal cancers. HPV vaccines prevent HPV infection …

Objectives Viral outbreaks are a frequent concern for humans. A great variety of drugs has
been used to treat viral diseases, which are not always safe and effective and may induce …

Globally, human papilloma virus (HPV) infection is a common sexually transmitted disease.
However, most of the HPV infections eventually resolve aided by the body's efficient cell …

Introduction Globally, sexually transmitted infections (STI) affect> 300 million people
annually, and are a major cause of sexual and reproductive health complications in women …

Human papillomavirus (HPV) infection is responsible for approximately 5% of all cancers
and is associated with 30% of all pathogen-related cancers. Cervical cancer is the third most …

Simple Summary Despite the implementation of efficient screening and vaccination
programs, uterine cervical cancer remains a leading cause of cancer-related mortality in …

HPVs representing the most common sexually transmitted disease are a group of
carcinogenic viruses with different oncogenic potential. The immune system and the vaginal …

Contraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34
million women worldwide. DMPA has been associated with increased risk of several viral …

Cervical cancer shows immense complexity at the epigenetic, genetic and cellular levels,
limiting conventional treatment. Immunotherapy has revolutionized nanomedicine and …

Human papillomavirus (HPV) is the most prevalent sexually transmitted virus globally.
Persistent high‐risk HPV infection can result in cervical precancerous lesions and cervical …